The Current Ratio as of June 2025 (TTM) for Laboratorios Farmaceuticos Rovi, S.A. (LABFF) is 3.14

According to Laboratorios Farmaceuticos Rovi, S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 3.14. This represents a change of 23.53% compared to the average of 2.54 of the last 4 quarters.

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Historical Current Ratio (quarterly & annually)

How has LABFF Current Ratio performed in the past?

The mean historical Current Ratio of Laboratorios Farmaceuticos Rovi, S.A. over the last ten years is 2.64. The current 3.14 Current Ratio has changed 11.79% with respect to the historical average. Over the past ten years (40 quarters), LABFF's Current Ratio was at its highest in in the September 2020 quarter at 3.28. The Current Ratio was at its lowest in in the June 2022 quarter at 1.77.

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Laboratorios Farmaceuticos Rovi, S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Average Current Ratio

How has LABFF Current Ratio performed in the past?

The current Current Ratio of Laboratorios Farmaceuticos Rovi, S.A. (LABFF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Current Ratio vs. Peers

How is LABFF’s Current Ratio compared to its peers?

Laboratorios Farmaceuticos Rovi, S.A.’s Current Ratio is less than Rezolute, Inc. (8.43), less than Cyteir Therapeutics, Inc. (28.07), less than XOMA Corporation (5.54), greater than Protagenic Therapeutics, Inc. (0.86), greater than Tempest Therapeutics, Inc. (1.70), less than Eliem Therapeutics, Inc. (31.41), less than Ikena Oncology, Inc. (13.31), less than Ovid Therapeutics Inc. (4.93), less than Connect Biopharma Holdings Limited (11.46), less than Edgewise Therapeutics, Inc. (20.99), less than Crinetics Pharmaceuticals, Inc. (22.53), less than Inhibrx Biosciences, Inc. (5.12), less than Merus N.V. (5.86), less than Lyell Immunopharma, Inc. (7.49), less than Kronos Bio, Inc. (12.93), less than Keros Therapeutics, Inc. (19.29), less than Janux Therapeutics, Inc. (58.47), less than Fennec Pharmaceuticals Inc. (5.13), less than Harmony Biosciences Holdings, Inc. (3.67), less than Merrimack Pharmaceuticals, Inc. (10.78), less than Celcuity Inc. (6.61), less than Enliven Therapeutics, Inc. (21.06),

Build a custom stock screener for Laboratorios Farmaceuticos Rovi, S.A. (LABFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Laboratorios Farmaceuticos Rovi, S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Laboratorios Farmaceuticos Rovi, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.